Literature DB >> 1801145

Absence of serological markers of infection with Trypanosoma brucei gambiense in domestic animals in a sleeping sickness focus in south Congo.

F Noireau1, J L Lemesre, T Vervoort.   

Abstract

A total of 33 domestic animals living in close contact with man in a human trypanosomiasis focus in South Congo were examined parasitologically and tested for serological markers of Trypanosoma brucei gambiense infection. 84.8% of the animals presented detectable T. congolense parasitaemia. The high rate of seropositivity observed with CATT (81.8%) contrasted with the low seroprevalence found with ELISA (less than 13%). None of the 33 plasma samples showed lytic antibodies when analysed by immune lysis test against 10 distinct T. b. gambiense predominant variable antigen types (LiTat 1.1 to 1.10). The results demonstrate the lack of specificity of CATT, and to a lesser extent ELISA, in detecting T. b. gambiense infection in animals. The seropositivity may be due to cross-reaction with certain T. congolense antigens. The absence of serological markers specific to T. b. gambiense confirms the parasitological data which estimate the prevalence rate of animals infected with Trypanozoon as less than 1% in the region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801145

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  2 in total

1.  Evaluation of diagnostic tests for Trypanosoma evansi in experimentally infected pigs and subsequent use in field surveys in north Vietnam and Thailand.

Authors:  W G Holland; N G Thanh; T T Do; S Sangmaneedet; B Goddeeris; J Vercruysse
Journal:  Trop Anim Health Prod       Date:  2005-08       Impact factor: 1.559

Review 2.  Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020.

Authors:  Irina Bemba; Roland Bamou; Arsene Lenga; Aline Okoko; Parfait Awono-Ambene; Christophe Antonio-Nkondjio
Journal:  J Med Entomol       Date:  2022-03-16       Impact factor: 2.278

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.